Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 249.39 Million AUD | 39.77% |
| 2022 | 178.43 Million AUD | 68.06% |
| 2021 | 106.17 Million AUD | 25.73% |
| 2020 | 84.44 Million AUD | 164.91% |
| 2019 | 31.87 Million AUD | 33.92% |
| 2018 | 23.8 Million AUD | 1221.74% |
| 2017 | 1.8 Million AUD | 0.0% |
| 2000 | 352 Thousand AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 341.98 Million AUD | 0.0% |
| 2023 Q2 | 231.83 Million AUD | 0.0% |
| 2023 Q4 | 249.39 Million AUD | 0.0% |
| 2023 FY | 249.39 Million AUD | 39.77% |
| 2022 Q4 | 178.43 Million AUD | 0.0% |
| 2022 FY | 178.43 Million AUD | 68.06% |
| 2022 Q2 | 109.28 Million AUD | 0.0% |
| 2021 FY | 106.17 Million AUD | 25.73% |
| 2021 Q4 | 106.17 Million AUD | 0.0% |
| 2021 Q2 | 79.85 Million AUD | 0.0% |
| 2020 FY | 84.44 Million AUD | 164.91% |
| 2020 Q4 | 84.44 Million AUD | 0.0% |
| 2020 Q2 | 44.6 Million AUD | 0.0% |
| 2019 Q2 | 22.29 Million AUD | 0.0% |
| 2019 Q4 | 31.87 Million AUD | 0.0% |
| 2019 FY | 31.87 Million AUD | 33.92% |
| 2018 Q4 | 23.8 Million AUD | 0.0% |
| 2018 FY | 23.8 Million AUD | 1221.74% |
| 2018 Q2 | 3.77 Million AUD | 0.0% |
| 2017 Q4 | 1.46 Million AUD | 0.0% |
| 2017 Q2 | 458 Thousand AUD | 0.0% |
| 2017 FY | 1.8 Million AUD | 0.0% |
| 2000 FY | 352 Thousand AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -5796.96% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -81174.829% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -2565.406% |
| Biome Australia Limited | 5.37 Million AUD | -4541.332% |
| Patrys Limited | 691.36 Thousand AUD | -35972.263% |
| Orthocell Limited | 22.08 Million AUD | -1029.353% |
| Imugene Limited | 33.14 Million AUD | -652.46% |
| Noxopharm Limited | 1.28 Million AUD | -19253.429% |
| PYC Therapeutics Limited | 10.18 Million AUD | -2348.829% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -1847.898% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -10623.898% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -15238.407% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -21196.267% |
| CSL Limited | 27.88 Billion AUD | 99.106% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -12026.161% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -67587.259% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | -787.128% |
| Starpharma Holdings Limited | 8.69 Million AUD | -2767.222% |
| Nanollose Limited | 465.64 Thousand AUD | -53458.413% |
| Memphasys Limited | 5.59 Million AUD | -4359.469% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -57678.885% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -290962.404% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -7177.666% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -6582.365% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -23750.925% |
| Race Oncology Limited | 1.91 Million AUD | -12913.345% |
| Nyrada Inc. | 855.63 Thousand AUD | -29046.959% |
| Dimerix Limited | 13.89 Million AUD | -1695.079% |
| PharmAust Limited | 896.6 Thousand AUD | -27714.974% |
| Immutep Limited | 10.97 Million AUD | -2171.403% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -2893.258% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -4496.488% |
| BTC Health Limited | 203.94 Thousand AUD | -122181.66% |
| Acrux Limited | 5.68 Million AUD | -4285.282% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | -483.193% |
| Biotron Limited | 737.5 Thousand AUD | -33715.362% |
| Tissue Repair Ltd | 1.35 Million AUD | -18361.045% |
| AdAlta Limited | 3.54 Million AUD | -6939.862% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | -458.133% |
| Hexima Limited | 248.67 Thousand AUD | -100189.942% |
| AnteoTech Limited | 4.07 Million AUD | -6019.639% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -6857.792% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | -1469.15% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -26387.563% |
| Actinogen Medical Limited | 1.61 Million AUD | -15338.649% |
| Immuron Limited | 2.84 Million AUD | -8679.75% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -10176.876% |